1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow hydrocortisone valerate: new trials by email Literature Review of hydrocortisone valerate trials Research Report on hydrocortisone valerate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) EZN-3042, Cytarabine, Doxorubicin - Lymphoblastic Leukemia, Acute, Lymphoblastic Leukemia, Acute, Childhood | Phase 1 | Terminated | Therapeutic Advances in Childhood Leukemia Consortium | 6 | 2010-08-24 | 2024-02-01 |
| Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD Total lymphoid irradiation, Rituximab, Anti-thymoglobulin, rabbit (ATG, rabbit ATG) - Leukemia, Mast-Cell, Mantle-cell Lymphoma | Phase 2 | Completed | Stanford University | 36 | 2005-06-01 | 2017-11-28 |
Leukemia (1) · Leukemia, Mast-Cell (1) · Lymphoma, Mantle-Cell (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
Stanford University (1) · Therapeutic Advances in Childhood Leukemia Consortium (1)
United States (2) · Australia (1)
David Miklos (1) · Elizabeth Raetz, MD (1) · William Carroll, MD (1)
P01CA049605 (1)